本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Zenas BioPharma Inc.

10.03
-0.1900-1.86%
盘后10.030.00000.00%13:41 EDT
成交量:14.57万
成交额:148.77万
市值:4.20亿
市盈率:-1.43
高:10.88
开:10.88
低:9.21
收:10.22
数据加载中...
2025/06/13

重要事件披露

Form 8-K - Current report
2025/06/04

重要事件披露

Form 8-K - Current report
2025/05/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/15

重要事件披露

Form 8-K - Current report
2025/03/11

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/11

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/05

重要事件披露

Form 8-K - Current report
2024/12/03

重要事件披露

Form 8-K - Current report
2024/11/12

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/12

重要事件披露

Form 8-K - Current report
2024/10/21

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/09/25

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/09/23

超过5%披露

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
2024/09/23

超过5%披露

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
2024/09/23

超过5%披露

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
2024/09/16

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/09/16

重要事件披露

Form 8-K - Current report
2024/09/11

SEC问询函

Form CORRESP - Correspondence
2024/09/11

SEC问询函

Form CORRESP - Correspondence
2024/09/06

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]